Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors

Daisuke Kikuchi, Toshiro Iizuka, Naohisa Yahagi, Hirotaka Maruno, Atushi Okazaki, Yusuke Takeda, Seizou Yamamoto, Hidetaka Kawabata, Masahiro Hayashi, Kazuma Kishi

Research output: Contribution to journalArticle

Abstract

Few experts can deal appropriately with metastatic bone tumors in the present situation. We developed a questionnaire about zoledronic acid for doctors with several specialties, and analyzed the differences in treatment strategy among various doctors retrospectively. Breast surgeons, have used zoledronic acid appropriately based on accurate knowledge, but it has been used inappropriately by doctors of other specialties due to lack of knowledge. Development of new treatment for metastatic bone tumors is awaited, but there is a possibility of inappropriate use as with zoledronic acid because of lack of knowledge and experience. So a medical team is necessary to provide the most recent knowledge of metastatic bone tumor and to enlighten other doctors.

Original languageEnglish
Pages (from-to)473-477
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Volume37
Issue number3
Publication statusPublished - 2010 Mar 6
Externally publishedYes

Fingerprint

zoledronic acid
Bone and Bones
Neoplasms
Breast
Therapeutics

Keywords

  • Cancer board
  • Metastatic bone tumor
  • Zoledronic acid

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors. / Kikuchi, Daisuke; Iizuka, Toshiro; Yahagi, Naohisa; Maruno, Hirotaka; Okazaki, Atushi; Takeda, Yusuke; Yamamoto, Seizou; Kawabata, Hidetaka; Hayashi, Masahiro; Kishi, Kazuma.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 37, No. 3, 06.03.2010, p. 473-477.

Research output: Contribution to journalArticle

Kikuchi, D, Iizuka, T, Yahagi, N, Maruno, H, Okazaki, A, Takeda, Y, Yamamoto, S, Kawabata, H, Hayashi, M & Kishi, K 2010, 'Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors', Japanese Journal of Cancer and Chemotherapy, vol. 37, no. 3, pp. 473-477.
Kikuchi, Daisuke ; Iizuka, Toshiro ; Yahagi, Naohisa ; Maruno, Hirotaka ; Okazaki, Atushi ; Takeda, Yusuke ; Yamamoto, Seizou ; Kawabata, Hidetaka ; Hayashi, Masahiro ; Kishi, Kazuma. / Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors. In: Japanese Journal of Cancer and Chemotherapy. 2010 ; Vol. 37, No. 3. pp. 473-477.
@article{42d84d51451a4a179ae0f766b65db851,
title = "Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors",
abstract = "Few experts can deal appropriately with metastatic bone tumors in the present situation. We developed a questionnaire about zoledronic acid for doctors with several specialties, and analyzed the differences in treatment strategy among various doctors retrospectively. Breast surgeons, have used zoledronic acid appropriately based on accurate knowledge, but it has been used inappropriately by doctors of other specialties due to lack of knowledge. Development of new treatment for metastatic bone tumors is awaited, but there is a possibility of inappropriate use as with zoledronic acid because of lack of knowledge and experience. So a medical team is necessary to provide the most recent knowledge of metastatic bone tumor and to enlighten other doctors.",
keywords = "Cancer board, Metastatic bone tumor, Zoledronic acid",
author = "Daisuke Kikuchi and Toshiro Iizuka and Naohisa Yahagi and Hirotaka Maruno and Atushi Okazaki and Yusuke Takeda and Seizou Yamamoto and Hidetaka Kawabata and Masahiro Hayashi and Kazuma Kishi",
year = "2010",
month = "3",
day = "6",
language = "English",
volume = "37",
pages = "473--477",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors

AU - Kikuchi, Daisuke

AU - Iizuka, Toshiro

AU - Yahagi, Naohisa

AU - Maruno, Hirotaka

AU - Okazaki, Atushi

AU - Takeda, Yusuke

AU - Yamamoto, Seizou

AU - Kawabata, Hidetaka

AU - Hayashi, Masahiro

AU - Kishi, Kazuma

PY - 2010/3/6

Y1 - 2010/3/6

N2 - Few experts can deal appropriately with metastatic bone tumors in the present situation. We developed a questionnaire about zoledronic acid for doctors with several specialties, and analyzed the differences in treatment strategy among various doctors retrospectively. Breast surgeons, have used zoledronic acid appropriately based on accurate knowledge, but it has been used inappropriately by doctors of other specialties due to lack of knowledge. Development of new treatment for metastatic bone tumors is awaited, but there is a possibility of inappropriate use as with zoledronic acid because of lack of knowledge and experience. So a medical team is necessary to provide the most recent knowledge of metastatic bone tumor and to enlighten other doctors.

AB - Few experts can deal appropriately with metastatic bone tumors in the present situation. We developed a questionnaire about zoledronic acid for doctors with several specialties, and analyzed the differences in treatment strategy among various doctors retrospectively. Breast surgeons, have used zoledronic acid appropriately based on accurate knowledge, but it has been used inappropriately by doctors of other specialties due to lack of knowledge. Development of new treatment for metastatic bone tumors is awaited, but there is a possibility of inappropriate use as with zoledronic acid because of lack of knowledge and experience. So a medical team is necessary to provide the most recent knowledge of metastatic bone tumor and to enlighten other doctors.

KW - Cancer board

KW - Metastatic bone tumor

KW - Zoledronic acid

UR - http://www.scopus.com/inward/record.url?scp=79960832957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960832957&partnerID=8YFLogxK

M3 - Article

C2 - 20332686

AN - SCOPUS:79960832957

VL - 37

SP - 473

EP - 477

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 3

ER -